Hepatitis C Sofosbuvir is Hitting the Egyptian Market

CAIRO: another medication for treating hepatitis C will be accessible on the Egyptian advertise ahead of schedule one month from now, Health Minister Adel al-Adawy reported Monday.

A 30,000-measurement shipment of Olisio, the new treatment, has landed in Egypt, and is right now experiencing tests before discharge available, the head of National Committee for the Control of Viral Hepatitis Waheed Doss told Youm 7.

Doss included that once Olisio is sanction, the treatment convention will be changed and the new medication will be utilized at the same time with the right now utilized American-made Sovaldi.

Lately, around 58,000 hepatitis C patients have been dealt with utilizing Sovaldi with a cure rate of 95 percent, as per authority reports.

Last September, an online enrollment procedure had begun for patients and authorities say that more than 872,000 had needed getting the state-financed Sovaldi.

Egypt has the most noteworthy rate of hepatitis C on the planet, as per the United Nations Population Fund; 14.7 percent of individuals between ages 15-49 have tried positive for the infection. Doss said that battling the contamination from the sickness itself is a top need for the service as number of patients increment yearly in the middle of 150,000 to 200,000 persons.